BJL
HRTX icon

Brighton Jones LLC’s Heron Therapeutics HRTX Stock Holding History

Brighton Jones LLC’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75K Buy
+11,133
New +$8.93K ﹤0.01% 1422

Other funds holding HRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Brighton Jones LLC's HRTX Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Heron Therapeutics (HRTX) in Q2 2026: 11,133 shares worth $4.75K. The stake represents ﹤0.01% of the portfolio and ranks #1422 among its holdings.

88 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Brighton Jones LLC held 11,133 shares of Heron Therapeutics worth $4.75K as of Q2 2026.
  • Heron Therapeutics was a new Brighton Jones LLC position in Q2 2026.
  • Heron Therapeutics made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1422 holding.
  • 88 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.